Please login to the form below

Not currently logged in
Email:
Password:

Synexus doubles its office capacity

Synexus, based in Lancashire, UK has doubled its head office capacity and forecasts strong growth in 2009

Synexus, based in Chorley, Lancashire, UK has doubled its head office capacity and forecasts strong growth again in 2009. The company made a 60 per cent increase in turnover in 2008.

Synexus, who recruit patients and run late stage primary care clinical trials, has achieved growth across the United Kingdom, Central and Eastern Europe, India and South Africa. The head office, from where Synexus manages its global network of 16 dedicated research centres, has 60 staff. The move into the new, modern premises also coincides with the installation of a state-of-the-art Cognos IT system which is intended to benefit the company's clients through the clinical study lifecycle.

Michael Fort, Synexus CEO said: "We are in the enviable position of continuing to enjoy robust growth during what for many are tough times. The increased capacity at our head office will support our growth and ensure we remain efficient. It's important to make sure our teams at head office are working in the right environment and also that we have room to grow – the re-vamped and extended offices do just that."

At the same time as Synexus enjoys success at home it is also developing its presence in Central and Eastern Europe with a recently opened regional office in Hungary headed by Dr Christian Tueni. Synexus already has sites in Poland and Bulgaria with several more planned.

27th July 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...

Infographics